Abstract:Introduction: The Coronavirus Disease 2019 (COVID-19) outbreak is a serious threat to humans, and the impact of COVID-19 on the liver remains unexplored. At present, no meta-analysis has summarized available findings of COVID-19 patients with liver injury in depth. Thus, we aimed to scrutinize the association of the liver in COVID-19 patients and approximate the prognosis of COVID-19 patients with liver injury thoroughly.Method: We searched different databases for qualified studies between December 2019 to May 2021. Finally, meta-analysis was carried out using fixed-effect or random-effect models based on the heterogeneity.Result: Our Meta-analysis includes 32 studies with a total of 6,933 COVID-19 patients. The pooled prevalence of chronic liver disease (CLD) was 3.5%. Overall, the rates of severity and mortality in COVID-19 patients with underlying CLD were 4.6% and 19.2%, respectively. Additionally, the incidence of acute on chronic failure (ACLF) among COVID-19 patients with CLD was 25.1%. The prevalence of an increase in serum ALT, AST, TBil, and LDH levels was 39.5%, 28.6%, 26.5%, and 55.5%, respectively. Similarly, PT was prolonged in 8.3% of cases, and albumin was decreased in 66.8% of cases. The pooled prevalence of liver injury among COVID-19 patients was 28.2%. Strikingly, the patients with liver injury had significantly more severe disease (42.3%) and a higher incidence of mortality (18.5%) than the patients without liver injury.Conclusion: In conclusion, more than one in five of the COVID-19 patients is at risk of developing a liver injury. Further, patients with liver injury have significantly more severe disease and a higher incidence of mortality than patients without liver injury. Thus, careful monitoring of liver function is advisable while treating COVID-19 patients.

COVID-19 Impact on Liver: Inter-Organ Cross-Talk in an Acute Inflammation

Liver Diseases in COVID-19: Etiology, Treatment and Prognosis

Liver diseases in COVID-19: Etiology, treatment and prognosis.

Liver injury in severe COVID-19 infection: current insights and challenges

COVID-19-associated liver injury: Adding fuel to the flame

Liver Injury in Patients with COVID-19: A Retrospective Study

COVID-19-associated liver injury: Clinical characteristics, pathophysiological mechanisms and treatment management

COVID-19 and Liver Dysfunction: Epidemiology, Association and Potential Mechanisms

Liver injury in COVID-19: an insight into pathobiology and roles of risk factors

Features of Liver Injury in COVID-19 Pathophysiological, Biological and Clinical Particularities

Insight into COVID-19 associated liver injury: Mechanisms, evaluation, and clinical implications

Molecular and Cellular Mechanisms of Liver Dysfunction in COVID-19.

Pathophysiological mechanisms of liver injury in COVID‐19

Liver injury in COVID-19: Clinical features, potential mechanisms, risk factors and clinical treatments

Liver injury in COVID-19: A minireview

COVID-19 and the liver: What do we know so far?

Pathogenetic Mechanisms of Liver-Associated Injuries, Management, and Current Challenges in COVID-19 Patients

Implications of liver injury in risk-stratification and management of patients with COVID-19

Recent advances in COVID-19-induced liver injury: causes, diagnosis, and management

COVID-19 is Associated with a High Prevalence of Liver Damage: a Systematic Review and Meta-Analysis

Histopathological impact of SARS-CoV-2 on the liver: Cellular damage and long-term complications